Wikidata

(Q61966956)

English

Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma

clinical trial

In more languages

Statements

short name
Flu-Mel-Vel (English)
0 references
title
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma Using a Conditioning Regimen of Fludarabine, Melphalan, and Bortezomib (English)
0 references
start time
9 June 2010
0 references
end time
May 2019
0 references
number of participants
55
0 references
research intervention
fludarabine phosphate
0 references
bortezomib
0 references
melphalan
0 references
vidarabine
0 references
minimum age
18 year
0 references
maximum age
69 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61966956&oldid=2091567992"